| Members |
targetComponentId |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 8 cm in greatest dimension (bone) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a category |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades muscularis propria (stomach) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Unilateral, one-half of one lobe or less (prostate) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b category |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor invades choroid focally (retinoblastoma) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor invades deep muscle (outer half) (urinary bladder) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor invades subserosa (stomach) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) |
American Joint Committee on Cancer pT2b (qualifier value) |
| pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c category |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Bilateral disease (prostate) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3 category |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Discontinuous tumors in the primary bone site (bone) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Extraprostatic extension (prostate) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades adventitia (esophagus) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades beyond muscularis into periureteric fat (ureter) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades pancreas (ampulla of Vater) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades perivesical tissue (urinary bladder) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 4 cm in greatest dimension (oropharynx) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 5 cm in greatest dimension (anal canal) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 5 cm in greatest dimension (breast) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung |
American Joint Committee on Cancer pT3 (qualifier value) |
| pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT3a (qualifier value) |
| pT3a (IIIA): Tumor involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT3a (qualifier value) |
| pT3a (IIIA): Tumor involves one or both fallopian tubes, with microscopic peritoneal metastasis outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT3a (qualifier value) |
| pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT3a (qualifier value) |
FHIR